Genetic Counseling Market Report 2026

Genetic Counseling Market Overview

• Genetic Counseling market size has reached to $1.96 billion in 2025 • Expected to grow to $3.54 billion in 2030 at a compound annual growth rate (CAGR) of 12.5% • Growth Driver: Growing Demand For Personalized Medicine Fueling The Growth Of The Market Due To Tailored Diagnosis And Treatment Advancements • Market Trend: Consumer-Initiated Genetic Testing Enhances Health Risk Awareness • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Genetic Counseling Market?

Genetic counseling is a process that helps individuals understand and adapt to the medical, psychological, and familial implications of genetic contributions to disease. It involves assessing the risk of inherited conditions, interpreting genetic testing results, and guiding informed decision-making. This process supports individuals and families in managing genetic health risks and making informed choices about their healthcare. The main types of genetic counseling include preconception counseling, prenatal counseling, carrier screening, and cancer risk assessment. Preconception counseling refers to a healthcare consultation that helps individuals or couples assess and manage medical, genetic, lifestyle, and environmental risks before attempting to conceive, in order to improve pregnancy outcomes. These counseling sessions are generally attended by patients, including individuals with genetic disorders, pregnant women, and family members of individuals with genetic disorders, and are delivered through different modes, including in-person sessions and telehealth. Genetic counseling supports applications such as proactive risk assessment, genetic consultation for intent-to-treat (ITT) patients, prenatal and preconception care, pediatric care, and others, serving key end users such as hospitals, clinics, diagnostic laboratories, research institutes, and others.

What Is The Genetic Counseling Market Growth Forecast?

The genetic counseling market size is expected to see rapid growth in the next few years. It will grow to $3.54 billion in 2030 at a compound annual growth rate (CAGR) of 12.5%. The growth in the forecast period can be attributed to increasing adoption of population-scale genetic screening, rising use of digital counseling platforms, expansion of personalized medicine initiatives, growing focus on preventive healthcare, increasing integration of genetic data into clinical decision-making. Major trends in the forecast period include increasing adoption of tele-genetic counseling services, rising demand for carrier screening programs, growing integration of digital genetic risk assessment tools, expansion of preventive and proactive genetic testing, enhanced focus on personalized patient education.

Global Genetic Counseling Market Segmentation

1) By Service Type: Preconception Counseling, Prenatal Counseling, Carrier Screening, Cancer Risk Assessment 2) By Patient Type: Individuals With Genetic Disorders, Pregnant Women, Family Members Of Individuals With Genetic Disorders 3) By Delivery Mode: In-Person, Telehealth 4) By Application: Proactive Risk Assessment, Genetic Consultation For Intent-To-Treat Patients (ITT), Prenatal And Preconception Care, Pediatric Care, Other Applications 5) By End-User: Hospitals, Clinics, Diagnostic Laboratories, Research Institutes, Other End-Users Subsegments: 1) By Preconception Counseling: Family History Evaluation, Genetic Risk Assessment, Carrier Status Analysis 2) By Prenatal Counseling: Non-Invasive Prenatal Testing, Amniocentesis Guidance, Ultrasound Risk Evaluation 3) By Carrier Screening: Targeted Mutation Analysis, Panel-Based Screening, Expanded Carrier Testing 4) By Cancer Risk Assessment: Breast Cancer (BRCA1 And BRCA2) Gene Mutation Analysis, Hereditary Cancer Panel Testing, Predictive Genetic Testing

What Is The Driver Of The Genetic Counseling Market?

The growing demand for personalized medicine is expected to propel the growth of the genetic counseling market going forward. Personalized medicine is a medical approach that involves tailoring treatments to individual patients based on their genetic, environmental, and lifestyle factors to optimize outcomes and improve care. The demand for personalized medicine is increasing due to advancements in genomic technologies, which enable the precise identification of genetic variations and tailored treatments for individuals. Genetic counseling supports personalized medicine by providing tailored insights based on an individual's genetic profile, enabling more precise diagnosis and treatment. It enhances patient care by guiding risk assessment, treatment decisions, and preventive strategies, improving overall healthcare outcomes. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, a significant increase from the 12 approved in 2022. Therefore, the growing demand for personalized medicine is driving the growth of the genetic counseling industry.

Key Players In The Global Genetic Counseling Market

Major companies operating in the genetic counseling market are Labcorp Holdings Inc., Quest Diagnostics Incorporated, Natera Inc., Myriad Genetics Inc., MedGenome Diagnostics Private Limited, GeneDx LLC, Color Health Inc., Ambry Genetics Corporation, Genome Medical Inc., Lilac Insights Private Limited, InformedDNA Inc., GeneScreen Counseling Inc., Anderson Diagnostics & Labs Private Limited, MyGeneCounsel LLC, Genetic Counselling India LLP, Genomic Valley Bharat Limited, Tandem Genetics LLC, Metis Genetics LLC, Sanmati Genetic Counseling Center, Invitae Corporation, Centogene N.V.

Global Genetic Counseling Market Trends and Insights

Major companies operating in the genetic counseling market are focusing on developing innovative solutions, such as consumer-initiated genetic testing platforms, to improve accessibility, personalization, and early detection of health risks. Consumer-initiated genetic testing platforms allow individuals to directly order genetic tests and receive personalized insights without visiting a healthcare provider. For instance, in July 2023, Quest Diagnostics Inc., a US-based diagnostic information services company, launched Genetic Insights, a consumer-initiated genetic testing solution. This test enables individuals to access actionable health risk insights, including genetic predispositions to certain conditions, without requiring a physician's order. This strategic offering is designed to empower individuals with insights into their potential genetic risk for a range of inherited health conditions, supported by comprehensive health reports and access to professional genetic counseling. This innovation enhances convenience, promotes proactive health management, and aligns with the growing demand for direct-to-consumer (DTC) genetic testing solutions.

What Are Latest Mergers And Acquisitions In The Genetic Counseling Market?

In March 2025, InformedDNA Inc., a US-based genetic counseling provider, acquired Coriell Life Sciences Inc. for an undisclosed amount. With this acquisition, InformedDNA aims to integrate Coriell’s pharmacogenomic testing and clinical decision support into its DNAimpact platform, enabling broader delivery of personalized medication guidance, improved treatment efficacy, and streamlined genetic insights for patients, providers, and payors. Coriell Life Sciences Inc. is a US-based provider of pharmacogenomic services and genetic counseling.

Regional Outlook

North America was the largest region in the genetic counseling market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Genetic Counseling Market?

The genetic counseling market includes revenues earned by entities through clinical interpretation, hereditary risk evaluation, wellness genomics, lifestyle-based genomic advice, post-test consultation and related educational resources, data analytics platforms, patient navigation services, outcome monitoring tools, and customized screening protocols. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Genetic Counseling Market Report 2026?

The genetic counseling market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the genetic counseling industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.